Fall in Human Papillomavirus Prevalence Following a National Vaccination Program

Abstract

Four years after the commencement of the Australian HPV vaccination program, a substantial decrease in vaccine-targeted genotypes is evident and should, in time, translate into reductions in HPV-related lesions.